Nurse Practitioner, Family · Salem, VA
NPI
1073040200
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
1900 Electric Rd
Salem, VA, 24153
Phone (540) 776-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
3,667 services
Medicare patients, 2024
359
Average age 71
Drug cost, 2024
$3.7M
6,209 prescriptions
Company payments, 2025
$2,237
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Beth A Hite was code J0897 (injection, denosumab, 1 mg), 2,280 times for 22 patients. In total Beth A Hite billed 3,667 services in 9 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,280 | 22 | $20.32 | $46K |
| 99213 Office E&M - Established | Office | 368 | 229 | $52.21 | $19K |
| 99214 Office E&M - Established | Office | 296 | 184 | $79.06 | $23K |
| 95251 Test - Miscellaneous | Office | 207 | 105 | $21.77 | $4,507 |
| 96372 Injection Administration | Office | 43 | 24 | $9.03 | $388 |
| 99204 Office E&M - New | Office | 39 | 39 | $99.60 | $3,884 |
By year: 2022 $87K for 3,645 services; 2023 $85K for 2,859 services; 2024 $102K for 3,667 services.
Medicare prescription drug claims, 2024
In 2024, the drug Beth A Hite prescribed most often to Medicare patients was Ozempic (Semaglutide), with 378 prescriptions and refills. In total Beth A Hite wrote 6,209 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 378 | 629 | 94 | $608K |
| Jardiance Empagliflozin | 322 | 589 | 71 | $341K |
| Farxiga Dapagliflozin Propanediol | 294 | 462 | 60 | $258K |
| Levothyroxine Sodium Generic | 269 | 646 | 76 | $3,625 |
| Mounjaro Tirzepatide | 264 | 336 | 56 | $358K |
| Glimepiride Generic | 240 | 604 | 62 | $1,787 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 224 | 514 | 69 | $41K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 213 | 324 | 44 | $241K |
| Trulicity Dulaglutide | 187 | 264 | 35 | $257K |
| Metformin Hcl Er Metformin Hcl | 180 | 430 | 57 | $1,828 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 167 | 422 | 71 | $19K |
| Metformin Hcl Generic | 154 | 464 | 57 | $805 |
| Tresiba Flextouch U-100 Insulin Degludec | 130 | 267 | 39 | $82K |
| Januvia Sitagliptin Phosphate | 120 | 166 | 26 | $93K |
| Unithroid Levothyroxine Sodium | 120 | 324 | 32 | $5,501 |
Brand drugs: 3,596 claims; generic drugs: 1,954 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Beth A Hite $2,237 ($2,237 in general payments such as food, travel and fees) from 15 companies. The largest payer was Dexcom, Inc. with $471.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 6 | $471 |
| Amgen Inc. AMGN | 15 | $346 |
| Novo Nordisk Inc NVO | 17 | $189 |
| Insulet Corporation PODD | 3 | $183 |
| Abbott Laboratories ABT | 8 | $170 |
| Lilly USA, LLC LLY | 17 | $163 |
| Inspire Medical Systems, Inc. INSP | 1 | $141 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $125 |
| Boston Scientific Corporation BSX | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.